title: The story of Vioxx--no pain and a lot of gain: ethical concerns regarding conduct of the pharmaceutical industry.
authors.affiliation: Postoperative and Interventional Pain Program, Department of Anesthesiology, Pharmacology and Surgical Intensive Care, Geneva University Hospital, 24 Rue Micheli-du-Crest, 1211 Geneva, 14, Geneva, Switzerland.
authors.forename: Alex
authors.initials: A
authors.lastname: Cahana
authors.forename: Alexandre
authors.initials: A
authors.lastname: Mauron
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects*; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000941:ethics / Q000331:legislation & jurisprudence / Q000592:standards*; D006801:Humans; D007783:Lactones / Q000009:adverse effects*; D040541:Marketing / Q000941:ethics; D013450:Sulfones / Q000009:adverse effects*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D052246:Cyclooxygenase 2 Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib